Scientists at the University of Birmingham in collaboration with the University of Amsterdam have uncovered a possible explanation for the mental sluggishness that often accompanies illness.
Introducing Jacqueline Ko, OMF and OMF Canada Ambassador, she is a multi-award-winning Canadian performer, producer, and disability advocate. She is known for her roles in opera, theatre, musical theatre and film, and is also the founding artistic director of Opera Mariposa, a Vancouver-based performing arts company that showcases opera’s rising stars.
The Third Annual Community Symposium on the Molecular Basis of ME/CFS, sponsored by OMF, took place on September 7, 2019 at Stanford University. It brought together hundreds of researchers, clinicians, patients, caregivers, families, and advocates, and thousands more by livestream.
The Metabolic Trap could be caused by a IDO2 mutation found in ME patients, Dr. Davis discusses the possible implications of this research.
A great review of recent research around ME/CFS by Dr. Henry Miller, Senior Fellow at the Pacific Research Institute.
Dr. Mike Snyder demonstrates how big data and wearable technology can lead to better health.
Dr. Juan Santiago presents his fascinating work on developing an ME/CFS bio-marker from observed Red Blood Cell Deformability.
Dr. Robert Phair presents an update on his theories and findings around Metabolic Trap research.
One year to the day of the Report’s initiation, Stephen Roberds, the Chair of the ME/CFS Working Group and an NANDSC Council member, stepped up before the National Advisory Council (NANDSC), the Council through which all NINDS grants, initiatives and projects must pass. Before becoming the group’s chair, Roberds knew nothing about chronic fatigue syndrome (ME/CFS), but a year working on the report has convinced him it is a serious and neglected disease. Follow the source link below for details and a link to the report.
The 2019 inaugural Harvard ME/CFS Collaboration Symposium group photo.
Harvard today launched a new informative ME/CFS website. It is described as part of a new collaborative initiative at the Harvard Medical School Institutions committed to the higher understanding and discovery of new treatments for ME/CFS.